1,536
Views
9
CrossRef citations to date
0
Altmetric
Research Article

Design, synthesis, and in vitro antiproliferative and kinase inhibitory effects of pyrimidinylpyrazole derivatives terminating with arylsulfonamido or cyclic sulfamide substituents

, , , , , , & show all
Pages 111-122 | Received 29 Feb 2016, Accepted 05 May 2016, Published online: 02 Jun 2016

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Nehal A. Hamdy, Mardia T. El Sayed, Hoda A. R. Hussein, Marwa M. Mounier & Manal M. Anwar. (2023) Synthesis of novel heterocyclic compounds bearing tetralin moiety of potential anticancer activity targeting the intrinsic apoptotic pathway. Synthetic Communications 53:4, pages 298-315.
Read now
Mohammed S. Abdel-Maksoud, Mohammed I. El-Gamal, Mahmoud M. Gamal El-Din & Chang Hyun Oh. (2019) Design, synthesis, in vitro anticancer evaluation, kinase inhibitory effects, and pharmacokinetic profile of new 1,3,4-triarylpyrazole derivatives possessing terminal sulfonamide moiety. Journal of Enzyme Inhibition and Medicinal Chemistry 34:1, pages 97-109.
Read now

Articles from other publishers (7)

George Mihai Nitulescu, Gheorghe Stancov, Oana Cristina Seremet, Georgiana Nitulescu, Dragos Paul Mihai, Cosmina Gabriela Duta-Bratu, Stefania Felicia Barbuceanu & Octavian Tudorel Olaru. (2023) The Importance of the Pyrazole Scaffold in the Design of Protein Kinases Inhibitors as Targeted Anticancer Therapies. Molecules 28:14, pages 5359.
Crossref
Davinder Kumar, Navidha Aggarwal, Aakash Deep, Harsh Kumar, Hitesh Chopra, Rakesh Kumar Marwaha & Simona Cavalu. (2023) An Understanding of Mechanism-Based Approaches for 1,3,4-Oxadiazole Scaffolds as Cytotoxic Agents and Enzyme Inhibitors. Pharmaceuticals 16:2, pages 254.
Crossref
Mohammed I. El-Gamal, Seyed-Omar Zaraei, Moustafa M. Madkour & Hanan S. Anbar. (2022) Evaluation of Substituted Pyrazole-Based Kinase Inhibitors in One Decade (2011–2020): Current Status and Future Prospects. Molecules 27:1, pages 330.
Crossref
Mohammed S. Abdel-Maksoud, Mohammed I. El-Gamal, Bong S. Lee, Mahmoud M. Gamal El-Din, Hong R. Jeon, Dow Kwon, Usama M. Ammar, Karim I. Mersal, Eslam M. H. Ali, Kyung-Tae Lee, Kyung Ho Yoo, Dong Keun Han, Jae Kyun Lee, Garam Kim, Hong Seok Choi, Young Jik Kwon, Kwan Hyi Lee & Chang Hyun Oh. (2021) Discovery of New Imidazo[2,1- b ]thiazole Derivatives as Potent Pan-RAF Inhibitors with Promising In Vitro and In Vivo Anti-melanoma Activity . Journal of Medicinal Chemistry 64:10, pages 6877-6901.
Crossref
Mohammed S. Abdel-Maksoud, Usama M. Ammar, Mohammed I. El-Gamal, Mahmoud M. Gamal El-Din, Karim I. Mersal, Eslam M.H. Ali, Kyung Ho Yoo, Kyung-Tae Lee & Chang-Hyun Oh. (2019) Design, synthesis, and anticancer activity of imidazo[2,1-b]oxazole-based RAF kinase inhibitors. Bioorganic Chemistry 93, pages 103349.
Crossref
Runjhun Tandon, Iqubal Singh, Vijay Luxami, Nitin Tandon & Kamaldeep Paul. (2018) Recent Advances and Developments of in vitro Evaluation of Heterocyclic Moieties on Cancer Cell Lines . The Chemical Record 19:2-3, pages 362-393.
Crossref
Mohammed I. El-Gamal, Byung-Jun Park & Chang-Hyun Oh. (2018) Synthesis, in vitro antiproliferative activity, and kinase inhibitory effects of pyrazole-containing diarylureas and diarylamides. European Journal of Medicinal Chemistry 156, pages 230-239.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.